Skip to main content

Advertisement

Log in

Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system

  • Public Health
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The study objective was to estimate secular trends in the overall incidence rate (IR) and prevalence rate (PR) of rheumatoid arthritis (RA); and subgroup-specific IR and PR by race, ethnicity, and sex in a multi-ethnic population of a large integrated health care delivery system. An ecological study was conducted within the adult population of Kaiser Permanente Southern California health plan. From January 1995 up to and including December 2014, annual IR and PR were calculated separately by race, ethnicity, sex and pooled overall. Depending on the stationarity of each ecological series, annual percentage change in IR and PR was evaluated using auto-regressive integrated moving average models. Average overall IR was 53 [95% confidence interval (CI) 46, 61] per 100,000 person-years. The overall as well as subgroup-specific annual IR of RA were unchanged from 1995 to 2014. In 1995, the overall PR of RA was 59 (44, 74) per 100,000 person-years which increased by 14% (7%, 21%) annually thereafter. The increase in PR in Caucasians was lower as compared to African American, Asian and other race (13% vs 15%, 15%, and 18%, respectively). Compared to non-Hispanic ethnicity, the increase in PR among Hispanic was higher (17% vs 14%). Over the past 2 decades, while the incidence of RA was unchanged, the prevalence had increased significantly overall as well as within every subgroup of race, ethnicity, and sex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25

    Article  Google Scholar 

  2. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County. Arthritis Rheum 62(6):1576–82 (Minnesota, 1955–2007)

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jean S, Hudson M, Gamache P et al (2017) Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol

  4. Dadoun S, Zeboulon-Ktorza N, Combescure C et al (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint, bone, spine: revue du rhumatisme 80(1):29–33

    Article  Google Scholar 

  5. Koebnick C, Langer-Gould AM, Gould MK et al (2012) Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Permanente J 16(3):37–41

    Article  Google Scholar 

  6. Granger CWJ, Newbold P (1974) Spurious regressions in econometrics. J Econ 2:111–120

    Article  Google Scholar 

  7. Phillips PCB (1986) Understanding spurious regressions in econometrics. J Econ 33:311–340

    Article  Google Scholar 

  8. Box GEP, Jenkins GM (1970) Time series analysis: forecasting and control. Holden-Day, San Francisco

    Google Scholar 

  9. Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI (2013) Time trends of incidence of age-associated diseases in the US elderly population: medicare-based analysis. Age Ageing 42(4):494–500

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA (2016) Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation Among US adults, 2015–2040. Arthritis Rheumatol 68(7):1582–1587

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM (2013) Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 65(2):334–342

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ajeganova S, Andersson ML, Frostegard J, Hafstrom I (2013) Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol

  13. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Therapy 11(3):229

    Article  Google Scholar 

  14. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732

    Article  PubMed  Google Scholar 

  15. Chu LH, Portugal C, Kawatkar AA, Stohl W, Nichol MB (2013) Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res 65(2):299–303

    Article  Google Scholar 

  16. Kawatkar AA, Hay JW, Stohl W, Nichol MB (2013) Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data. Health Econ 22(7):807–823

    Article  PubMed  Google Scholar 

  17. Ezzati M, Riboli E (2013) Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 369(10):954–964

    Article  CAS  Google Scholar 

  18. Demoruelle MK, Deane KD (2012) Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep 14(5):472–480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF (2013) Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 72(9):1436–1444

    Article  CAS  PubMed  Google Scholar 

  20. Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188

    Article  PubMed  Google Scholar 

  21. Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW (2008) Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med 168(15):1664–1670

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kaipiainen-Seppanen O, Kautiainen H (2006) Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980–2000. J Rheumatol 33(11):2132–2138

    PubMed  Google Scholar 

  23. Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K (2009) Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 29(4):411–415

    Article  PubMed  Google Scholar 

  24. Pedersen JK, Svendsen AJ, Horslev-Petersen K (2007) Incidence of Rheumatoid Arthritis in the southern part of Denmark from 1995 to 2001. Open Rheumatol J 1:18–23

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA (2009) Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 38(3):173–177

    Article  PubMed  Google Scholar 

  26. MacGregor AJ, Silman AJ (1992) A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. J Rheumatol 19(8):1163–1165

    CAS  PubMed  Google Scholar 

  27. Minichiello E, Semerano L, Boissier MC (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint, Bone, Spine: revue du rhumatisme 83(6):625–630

    Article  Google Scholar 

  28. Englund M, Joud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF (2010) Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology 49(8):1563–1569

    Article  PubMed  Google Scholar 

  29. Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J (2013) Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res 65(6):870–878

    Article  Google Scholar 

  30. Odegard S, Kvien TK, Uhlig T (2008) Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol 35(1):54–60

    PubMed  Google Scholar 

Download references

Funding

There was no funding received for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aniket A. Kawatkar.

Ethics declarations

Conflict of interest

Aniket A. Kawatkar, Sherine E. Gabriel, and Steven J. Jacobsen have no direct conflict of interests. Dr. Kawatkar reports grants from Medac Pharma, grants from Bristol-Myers Squibb, outside the submitted work.

Ethical approval

The study was approved by the Kaiser Permanente Southern California Institutional Review Board.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawatkar, A.A., Gabriel, S.E. & Jacobsen, S.J. Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system. Rheumatol Int 39, 541–549 (2019). https://doi.org/10.1007/s00296-018-04235-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-04235-y

Keywords

Navigation